跳至主要内容
临床试验/EUCTR2022-000660-22-AT
EUCTR2022-000660-22-AT进行中(未招募)1 期

Investigation to assess the efficacy of topical benzyl benzoate 10/25% emulsion versus permethrin 5% creme for scabies treatment - Investigation of benzyl benzoate 25% emulsion versus permethrin 5% creme in scabies

andeskrankenhaus Salzburg0 个研究点目标入组 100 人开始时间: 2022年3月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - diagnosis of scabies (dermatoscopically confirmed)
  • - age =6 years
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 100
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • -Scabies crustosa
  • - use of topical Permethrin (e.g. Infectoscab 5% Creme®) or Benzyl Benzoate emulsion or oral ivermectin within the last 3 weeks
  • exception: childres 6-18 years and or adults with high mite density (>5 mites) can be included 2 weeks after pre-treatment.
  • - allergy or intolerance agains top. benzyl benzoate emulsion or permethrin cream
  • - mental disfunction
  • - pregnancy/breast-feeding
  • - alcohol abuse

研究者

发起方
andeskrankenhaus Salzburg

相似试验